Crossref journal-article
Springer Science and Business Media LLC
Cancer Chemotherapy and Pharmacology (297)
Bibliography

Liebmann, J., Cook, J. A., Lipschultz, C., Teague, D., Fisher, J., & Mitchell, J. B. (1994). The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol�) in human tumor cell lines. Cancer Chemotherapy and Pharmacology, 33(4), 331–339.

Authors 6
  1. James Liebmann (first)
  2. John A. Cook (additional)
  3. Claudia Lipschultz (additional)
  4. Diane Teague (additional)
  5. Joyce Fisher (additional)
  6. James B. Mitchell (additional)
References 18 Referenced 81
  1. Brenner SL, Brinkley BR (1982) Tubulin assembly sites and the organization of microtubule arrays in mammalian cells. Cold Spring Harbor Symp Quant Biol 46:241 (10.1101/SQB.1982.046.01.027) / Cold Spring Harbor Symp Quant Biol by SL Brenner (1982)
  2. Chaung LF, Israel M, Chuang RY (1991) Cremophor EL inhibits 12-O-tetradecanoylphorbol-13 acetate (TPA)-induced protein phosphorylation in human myeloblastic leukemia ML-1 cells. Anticancer Res 11:1517 / Anticancer Res by LF Chaung (1991)
  3. Cook JA, DeGraff W, Teague D, Liebmann JE (1993) Radiation sensitization of Chinese hamster V79 cells by paclitaxel. Radiat Oncol Invest (in press) (10.1002/roi.2970010205)
  4. Cook JA, Liebmann J, Sullivan F, Hahn S, Teague D, DeGraff W, Mitchell JB (1993) Paclitaxel-mediated cytotoxicity in Chinese hamster V79 cells. Cancer Chemother Pharmacol (in press)
  5. Fox MH (1980) A model for the computer analysis of synchronous DNA distributions obtained by flow cytometry. Cytometry 1:71 (10.1002/cyto.990010114) / Cytometry by MH Fox (1980)
  6. Hahn SM, Liebmann JE, Fisher J, Cook JA, Mitchell JB, Kaufman DK (1993) Paclitaxel in combination with doxorubicin and etoposide: possible antagonism in vitro. Cancer (in press) (10.1002/1097-0142(19931101)72:9<2705::AID-CNCR2820720930>3.0.CO;2-K)
  7. Liebmann JE, Hahn SM, Cook JA, Lipschultz CA, Mitchell JB, Kaufman DC (1993) Glutathione depletion byl-buthionine sulfoximine antagonizes taxol cytotoxicity. Cancer Res 53:2066 / Cancer Res by JE Liebmann (1993)
  8. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, Mitchell JB (1993) Cytotoxic studies of paclitaxel (Taxol®) in human tumor cell lines. Br J Cancer (in press) (10.1038/bjc.1993.488)
  9. Lopes NM, Adams EG, Pitts TW, Bhuyan BK (1993) Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32:235 (10.1007/BF00685842) / Cancer Chemother Pharmacol by NM Lopes (1993)
  10. Manfredl JJ, Horwitz SB (1984) Taxol: an antimitotic agent with a unique mechanism of action. Pharmacol Ther 25:83 (10.1016/0163-7258(84)90025-1) / Pharmacol Ther by JJ Manfredl (1984)
  11. Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, Phillips M, Hurowitz L, Almadrones L, Hoskins W (1992) Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study. J Clin Oncol 10:1485 (10.1200/JCO.1992.10.9.1485) / J Clin Oncol by M Markman (1992)
  12. Rao S, Horwitz SB, Ringel I (1992) Direct photoaffinity labeling of tubulin with taxol. J Natl Cancer Inst 84:785 (10.1093/jnci/84.10.785) / J Natl Cancer Inst by S Rao (1992)
  13. Rowinsky EK, Caenave LA, Donehower RC (1990) Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82:1247 (10.1093/jnci/82.15.1247) / J Natl Cancer Inst by EK Rowinsky (1990)
  14. Schiff PB, Fant J, Auster LA, Horwitz SB (1978) Effects of taxol on cell growth and in vitro microtubule assembly. J Supramol Struct [Suppl] 2:328 / J Supramol Struct by PB Schiff (1978)
  15. Schiff PB, Fant J, Horwitz SB (1979) Promotion of microtubule assembly in vitro by taxol. Nature 277:665 (10.1038/277665a0) / Nature by PB Schiff (1979)
  16. Wani MC, Taylor HL, Wall ME, Coggon P, McPhail AT (1971) Plant antitumor agents. VI. The isolation and structure of Taxol, a novel antileukemic and antitumor agent fromTaxus brevifolia. J Am Chem Soc 93:2325 (10.1021/ja00738a045) / J Am Chem Soc by MC Wani (1971)
  17. Wiernik PH, Schwertz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E (1987) Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47:2486 / Cancer Res by PH Wiernik (1987)
  18. Woodeock DM, Jefferson S, Linsenmeyer ME, Crowther PJ, Chojnowski GM, Williams B, Bertoncello I (1990) Reversal of the multidrug resistance phenotype with Cremophor EL, a common vehicle for water-insoluble vitamins and drugs. Cancer Res 50:4199 / Cancer Res by DM Woodeock (1990)
Dates
Type When
Created 20 years, 9 months ago (Nov. 28, 2004, 11:19 p.m.)
Deposited 6 years, 5 months ago (April 5, 2019, 2:10 a.m.)
Indexed 4 weeks, 1 day ago (Aug. 7, 2025, 4:53 a.m.)
Issued 31 years, 8 months ago (Jan. 1, 1994)
Published 31 years, 8 months ago (Jan. 1, 1994)
Published Print 31 years, 8 months ago (Jan. 1, 1994)
Funders 0

None

@article{Liebmann_1994, title={The influence of Cremophor EL on the cell cycle effects of paclitaxel (Taxol�) in human tumor cell lines}, volume={33}, ISSN={1432-0843}, url={http://dx.doi.org/10.1007/bf00685909}, DOI={10.1007/bf00685909}, number={4}, journal={Cancer Chemotherapy and Pharmacology}, publisher={Springer Science and Business Media LLC}, author={Liebmann, James and Cook, John A. and Lipschultz, Claudia and Teague, Diane and Fisher, Joyce and Mitchell, James B.}, year={1994}, pages={331–339} }